ALDH-1 |
Aldehyde dehydrogenase-1 |
CA 19-9 |
Carbohydrate antigen 19-9 |
CSCs |
Cancer stem cells |
CXCR4 00 |
CX-C chemokine receptor type 4 |
DMEM |
Dulbecco’s Modified Eagle’s Medium |
EMT |
Epithelial–mesenchymal transition |
FBS |
Fetal bovine serum |
FoxM1 |
Forkhead box protein M1 |
HPDE |
Human pancreatic ductal epithelial cell line |
IDT |
Integrated DNA Technologies |
IPMN |
Intraductal papillary mucinous neoplasm |
KOs |
Knockouts |
MAPK |
Mitogen-activated protein kinase |
MDSCs |
Myeloid-derived suppressor cells |
miRs |
microRNAs |
mTOR |
Mammalian target of rapamycin |
nMDSCs |
Neutrophil-like heterogeneous myeloid-derived suppressor cells |
NF-κB |
Nuclear factor kappa-light-chain-enhancer of activated B cells |
oncomiR |
Oncogenic miR |
PanIN |
Pancreatic intraepithelial neoplasia |
PCa |
Pancreatic cancer |
PCSCs |
Pancreatic cancer stem cells |
PDAC |
Pancreatic ductal adenocarcinoma |
PDCD4 |
Programmed cell death 4 |
PDGF |
Platelet-derived growth factor |
PI3K |
Phosphoinositide-3-kinase |
PNI |
Perineural invasion |
RPII |
RNA polymerase 2 |
SD |
Standard Deviation |
SHH |
Sonic Hedgehog |
TNM |
Tumor-Node-Metastasis |
UTRs |
Untranslated regions |
VEGF |
Vascular endothelial growth factor |
ZEB1 |
Zinc Finger E-box binding homeobox 1 |